PEN vs. LNTH, ITGR, GEHC, PHG, ZBH, SNN, SOLV, STVN, IRTC, and BLCO
Should you be buying Penumbra stock or one of its competitors? The main competitors of Penumbra include Lantheus (LNTH), Integer (ITGR), GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Smith & Nephew SNATS (SNN), Solventum (SOLV), Stevanato Group (STVN), iRhythm Technologies (IRTC), and Bausch + Lomb (BLCO). These companies are all part of the "medical" sector.
Penumbra vs. Its Competitors
Lantheus (NASDAQ:LNTH) and Penumbra (NYSE:PEN) are both mid-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability.
99.1% of Lantheus shares are held by institutional investors. Comparatively, 88.9% of Penumbra shares are held by institutional investors. 2.0% of Lantheus shares are held by company insiders. Comparatively, 4.2% of Penumbra shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Lantheus currently has a consensus price target of $85.50, suggesting a potential upside of 62.24%. Penumbra has a consensus price target of $302.93, suggesting a potential upside of 18.63%. Given Lantheus' higher possible upside, analysts plainly believe Lantheus is more favorable than Penumbra.
Lantheus has higher revenue and earnings than Penumbra. Lantheus is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.
In the previous week, Lantheus had 11 more articles in the media than Penumbra. MarketBeat recorded 30 mentions for Lantheus and 19 mentions for Penumbra. Penumbra's average media sentiment score of 0.81 beat Lantheus' score of 0.07 indicating that Penumbra is being referred to more favorably in the news media.
Lantheus has a net margin of 17.82% compared to Penumbra's net margin of 11.54%. Lantheus' return on equity of 34.06% beat Penumbra's return on equity.
Lantheus has a beta of 0.09, indicating that its stock price is 91% less volatile than the S&P 500. Comparatively, Penumbra has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500.
Summary
Lantheus and Penumbra tied by winning 8 of the 16 factors compared between the two stocks.
Get Penumbra News Delivered to You Automatically
Sign up to receive the latest news and ratings for PEN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding PEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Penumbra Competitors List
Related Companies and Tools
This page (NYSE:PEN) was last updated on 10/6/2025 by MarketBeat.com Staff
